Editorial NexoScience
Swallowing an iron pill every morning might move a number on a lab report without doing much for how exhausted you actually feel, at least according to the largest pooled analysis yet of oral iron supplements in athletes.
Iron deficiency without anemia is far more common in physically active people than most realize. Hemoglobin can stay perfectly normal while ferritin, the protein that stores iron inside cells, quietly drops. Left untreated, that early stage can slide into full iron deficiency anemia. Estimates put the prevalence of iron deficiency at 3 to 11 percent in male athletes and 15 to 35 percent in female athletes, driven by heavy sweating, gut bleeding from prolonged exercise, and menstrual losses on top of training that is often paired with restrictive eating.
To find out whether popping an iron supplement actually fixes any of that, researchers pooled 13 randomized controlled trials covering 449 healthy, physically active adults, 432 of them women, screened down from 638 papers identified in the original search. Every included study compared an experimental group taking oral iron against a placebo or untreated control group.
Ferritin went up. Almost nothing else moved by a meaningful margin. Supplementation produced a large, statistically significant increase in serum ferritin (standardized mean difference of 1.27, with the effect holding up even after the most influential study was removed). Blood hemoglobin also trended upward, but the increase was not statistically significant, and neither were the changes in transferrin receptor concentration or transferrin saturation, two other markers doctors use to judge iron status.
Physical performance barely budged either. Across 8 trials measuring maximal oxygen consumption, or VO2max, supplementation produced only a small, statistically non-significant trend toward improvement, and the authors flagged that the quality of evidence behind that number was low.
Who actually benefited depended heavily on how depleted they were to begin with. Subgroup analysis showed the ferritin boost was concentrated almost entirely in athletes who started with pre-supplementation ferritin at or below 12 micrograms per liter, the threshold used to define iron deficiency anemia. Athletes who started above that cutoff saw only minimal, if any, gains. Even among those who did respond, ferritin stayed below 35 micrograms per liter, the marker for early-stage iron deficiency, in 10 of the 13 studies after supplementation ended.
Dose and duration turned out to matter more than most people assume. The protocols that produced measurable benefits used between 16 and 100 milligrams of elemental iron a day, taken for 6 to 8 weeks. Trials that ran shorter courses reported no meaningful change in either ferritin or hemoglobin, which the authors point to as a likely explanation for some of the disappointing results scattered through the individual studies.
The evidence itself comes with real caveats. Heterogeneity between studies was high for nearly every outcome, sample sizes were modest, most participants were women, and few of the trials tracked participants’ inflammation status or their baseline dietary iron intake, both of which can distort how ferritin readings should be interpreted.
None of this is a green light to start self-prescribing iron. Oral iron supplements can cause significant gastrointestinal side effects, and professional guidelines from the Academy of Nutrition and Dietetics, Dietitians of Canada, and the American College of Sports Medicine already recommend against routine, unmonitored iron supplementation without confirmed evidence of depletion from a blood test. The honest takeaway from this analysis is narrower than the supplement aisle would suggest: iron pills can restock genuinely low iron stores over a couple of months, but they are not a shortcut to more energy or a faster finish time for someone whose iron was never actually low.
The study, “Effects of Oral Iron Supplementation on Blood Iron Status in Athletes: A Systematic Review, Meta-Analysis and Meta-Regression of Randomized Controlled Trials,” was led by Anja Neža Šmid and colleagues at the University of Ljubljana and published in Sports Medicine (DOI: 10.1007/s40279-024-01992-8).
